Veramarx, Inc. Alternatives & Competitors

12 companies similar to Veramarx, Inc.

Selah Genomics Inc

1 Debt Financing $1.35M

Greenville, United States

Biotechnology Health Care

Biocartis

High precision diagnostics for personalized medicine

314 Grant $322.90M

Mechelen, Belgium

Biotechnology Health Care +1

IMMY

Saving Lives One Diagnostic at a Time

116

Norman, United States

Biotechnology Health Care +1

Track all Veramarx, Inc. competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Redcliffe Labs

Healthy India Ki Trusted Lab

1663 Venture round $109.93M

Noida, India

Health Care Life Sciences

Immunovia AB

Advancing early detection of pancreatic cancer

17 Grant

Lund, Sweden

Biotechnology Health Care

EMPE Diagnostics

Confirmatory precision diagnostics for tuberculosis (MDR/XDR-TB) within 3 h even at resour...

27 Series A $42.94M

Solna, Sweden

Biotechnology Health Care +2

Kaminari Medical

Combining ultrasound and optical imaging to revolutionize coronary revascularization

10 Seed $300.00K

Rotterdam, The Netherland...

Health Care Medical Devices

Nucleix Ltd.

Developing cancer diagnostic panels based on epigenetic bio markers

72 $82.25M

Rehovot, Israel

Biotechnology Health Care +4

Day Zero Diagnostics, Inc

The future of infectious disease diagnostics starts at Day Zero.

64 $63.00M

Boston, United States

Biotechnology Health Care +1

JaxBio

At JaxBio we develop a blood test for fast, cheap and highly sensitive diagnosis of cancer...

11 Grant $2.50M

Health Care

Sienna Cancer Diagnostics - A BARD1 Life Sciences company

Developing and commercialising IVD tests that address unmet clinical and market needs in t...

Notting Hill, Australia

Biopharma Biotechnology +2

Frequently Asked Questions

Companies similar to Veramarx, Inc. include Selah Genomics Inc, PrognostX Health, Biocartis, IMMY, Redcliffe Labs. They work in Health Care.

Bounce Watch lists 12 companies that share Veramarx, Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

Veramarx, Inc. focuses on providing accurate diagnostic tests for early-stage Lyme disease, which is a rapidly growing infectious disease in the US and Western Europe. According to their description, the current diagnostic tests for Lyme disease are highly inaccurate, missing over 60% of cases in the early stage.

Don't just read about them. Follow them.

BounceWatch watches Veramarx, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Veramarx, Inc. Profile PrognostX Health Alternatives Biocartis Alternatives Immunovia AB Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Veramarx, Inc. on 12 Sep 2024. The 11 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.